A $1 billion fund backed by over 20 drugmakers made its first set of investments on April 4 in two biotechnology startups, nearly two years after it was launched to help struggling antibiotic makers tackle the threat of antibiotic-resistant bacteria.

Scientists have found multidrug-resistant “superbug” bacteria lurking on cash machines, escalators and handrails in London’s underground rail system, shopping centers and hospitals and say they pose a potential risk to public health.

U.S. health regulators approved Tetraphase Pharmaceuticals Inc.’s drug to treat complicated intra-abdominal infections.

Merck is globally committed to an antimicrobial stewardship encompassing surveillance, R&D, and health policy.

Swiss drugmaker Roche Holding has dropped out of a high-profile project to develop an antibiotic for treating “superbug” infections, the company said on Sunday.   Roche had agreed in 2013 […]

A new gene that makes bacteria highly resistant to a last-resort class of antibiotics has been found in people and pigs in China – including in samples of bacteria with […]

People across the world are alarmingly confused about the role of antibiotics and the right way to take them, and this ignorance is fuelling the rise of drug-resistant superbugs, the […]

For the first time, tuberculosis infections rivaled HIV/AIDS as a leading cause of death from infectious diseases, the World Health Organization said in a report released on Wednesday.   It […]

The U.S. Food and Drug Administration has ordered three Japanese manufacturers of duodenoscopes to conduct studies to evaluate how the devices are being used, as part of its effort to […]

A non-antibiotic drug already tested in people for other uses may be active in treating Clostridium difficile, a superbug that preys on people whose protective gut bacteria have been wiped […]